178 related articles for article (PubMed ID: 22071890)
1. ALK germline mutations in patients with neuroblastoma: a rare and weakly penetrant syndrome.
Bourdeaut F; Ferrand S; Brugières L; Hilbert M; Ribeiro A; Lacroix L; Bénard J; Combaret V; Michon J; Valteau-Couanet D; Isidor B; Rialland X; Poirée M; Defachelles AS; Peuchmaur M; Schleiermacher G; Pierron G; Gauthier-Villars M; Janoueix-Lerosey I; Delattre O;
Eur J Hum Genet; 2012 Mar; 20(3):291-7. PubMed ID: 22071890
[TBL] [Abstract][Full Text] [Related]
2. Germline mutations of the paired-like homeobox 2B (PHOX2B) gene in neuroblastoma.
Bourdeaut F; Trochet D; Janoueix-Lerosey I; Ribeiro A; Deville A; Coz C; Michiels JF; Lyonnet S; Amiel J; Delattre O
Cancer Lett; 2005 Oct; 228(1-2):51-8. PubMed ID: 15949893
[TBL] [Abstract][Full Text] [Related]
3. Identification of ALK as a major familial neuroblastoma predisposition gene.
Mossé YP; Laudenslager M; Longo L; Cole KA; Wood A; Attiyeh EF; Laquaglia MJ; Sennett R; Lynch JE; Perri P; Laureys G; Speleman F; Kim C; Hou C; Hakonarson H; Torkamani A; Schork NJ; Brodeur GM; Tonini GP; Rappaport E; Devoto M; Maris JM
Nature; 2008 Oct; 455(7215):930-5. PubMed ID: 18724359
[TBL] [Abstract][Full Text] [Related]
4. Two siblings with familial neuroblastoma with distinct clinical phenotypes harboring an ALK germline mutation.
Kudo K; Ueno H; Sato T; Kubo K; Kanezaki R; Kobayashi A; Kamio T; Sasaki S; Terui K; Kurose A; Yoshida K; Shiozawa Y; Toki T; Ogawa S; Ito E
Genes Chromosomes Cancer; 2018 Dec; 57(12):665-669. PubMed ID: 30350464
[TBL] [Abstract][Full Text] [Related]
5. Germline mutations of the paired-like homeobox 2B (PHOX2B) gene in neuroblastoma.
Trochet D; Bourdeaut F; Janoueix-Lerosey I; Deville A; de Pontual L; Schleiermacher G; Coze C; Philip N; Frébourg T; Munnich A; Lyonnet S; Delattre O; Amiel J
Am J Hum Genet; 2004 Apr; 74(4):761-4. PubMed ID: 15024693
[TBL] [Abstract][Full Text] [Related]
6. Somatic and germline activating mutations of the ALK kinase receptor in neuroblastoma.
Janoueix-Lerosey I; Lequin D; Brugières L; Ribeiro A; de Pontual L; Combaret V; Raynal V; Puisieux A; Schleiermacher G; Pierron G; Valteau-Couanet D; Frebourg T; Michon J; Lyonnet S; Amiel J; Delattre O
Nature; 2008 Oct; 455(7215):967-70. PubMed ID: 18923523
[TBL] [Abstract][Full Text] [Related]
7. Analysis of neuroblastoma tumour progression; loss of PHOX2B on 4p13 and 17q gain are early events in neuroblastoma tumourigenesis.
Krona C; Carén H; Sjöberg RM; Sandstedt B; Laureys G; Kogner P; Martinsson T
Int J Oncol; 2008 Mar; 32(3):575-83. PubMed ID: 18292934
[TBL] [Abstract][Full Text] [Related]
8. PHOX2B-mediated regulation of ALK expression: in vitro identification of a functional relationship between two genes involved in neuroblastoma.
Bachetti T; Di Paolo D; Di Lascio S; Mirisola V; Brignole C; Bellotti M; Caffa I; Ferraris C; Fiore M; Fornasari D; Chiarle R; Borghini S; Pfeffer U; Ponzoni M; Ceccherini I; Perri P
PLoS One; 2010 Oct; 5(10):. PubMed ID: 20957039
[TBL] [Abstract][Full Text] [Related]
9. Genetic susceptibility to neuroblastoma.
Tolbert VP; Coggins GE; Maris JM
Curr Opin Genet Dev; 2017 Feb; 42():81-90. PubMed ID: 28458126
[TBL] [Abstract][Full Text] [Related]
10. Clinical feature of anaplastic lymphoma kinase-mutated neuroblastoma.
Ogura T; Hiyama E; Kamei N; Kamimatsuse A; Ueda Y; Ogura K
J Pediatr Surg; 2012 Oct; 47(10):1789-96. PubMed ID: 23084186
[TBL] [Abstract][Full Text] [Related]
11. High-resolution array CGH profiling identifies Na/K transporting ATPase interacting 2 (NKAIN2) as a predisposing candidate gene in neuroblastoma.
Romania P; Castellano A; Surace C; Citti A; De Ioris MA; Sirleto P; De Mariano M; Longo L; Boldrini R; Angioni A; Locatelli F; Fruci D
PLoS One; 2013; 8(10):e78481. PubMed ID: 24205241
[TBL] [Abstract][Full Text] [Related]
12. Germline gain-of-function mutations of ALK disrupt central nervous system development.
de Pontual L; Kettaneh D; Gordon CT; Oufadem M; Boddaert N; Lees M; Balu L; Lachassinne E; Petros A; Mollet J; Wilson LC; Munnich A; Brugière L; Delattre O; Vekemans M; Etchevers H; Lyonnet S; Janoueix-Lerosey I; Amiel J
Hum Mutat; 2011 Mar; 32(3):272-6. PubMed ID: 21972109
[TBL] [Abstract][Full Text] [Related]
13. Retinoblastoma and Neuroblastoma Predisposition and Surveillance.
Kamihara J; Bourdeaut F; Foulkes WD; Molenaar JJ; Mossé YP; Nakagawara A; Parareda A; Scollon SR; Schneider KW; Skalet AH; States LJ; Walsh MF; Diller LR; Brodeur GM
Clin Cancer Res; 2017 Jul; 23(13):e98-e106. PubMed ID: 28674118
[TBL] [Abstract][Full Text] [Related]
14. PHOX2B mutations and genetic predisposition to neuroblastoma.
Perri P; Bachetti T; Longo L; Matera I; Seri M; Tonini GP; Ceccherini I
Oncogene; 2005 Apr; 24(18):3050-3. PubMed ID: 15735672
[TBL] [Abstract][Full Text] [Related]
15. Genome-wide linkage analysis to identify genetic modifiers of ALK mutation penetrance in familial neuroblastoma.
Devoto M; Specchia C; Laudenslager M; Longo L; Hakonarson H; Maris J; Mossé Y
Hum Hered; 2011; 71(2):135-9. PubMed ID: 21734404
[TBL] [Abstract][Full Text] [Related]
16. Multifocal primary neuroblastoma tumor heterogeneity in siblings with co-occurring PHOX2B and NF1 genetic aberrations.
Rybinski B; Wolinsky T; Brohl A; Moerdler S; Reed DR; Ewart M; Weiser D
Genes Chromosomes Cancer; 2020 Feb; 59(2):119-124. PubMed ID: 31515834
[TBL] [Abstract][Full Text] [Related]
17. Copy number status and mutation analyses of anaplastic lymphoma kinase (ALK) gene in 90 sporadic neuroblastoma tumors.
Bagci O; Tumer S; Olgun N; Altungoz O
Cancer Lett; 2012 Apr; 317(1):72-7. PubMed ID: 22085494
[TBL] [Abstract][Full Text] [Related]
18. Oncologic Phenotype of Peripheral Neuroblastic Tumors Associated With PHOX2B Non-Polyalanine Repeat Expansion Mutations.
Heide S; Masliah-Planchon J; Isidor B; Guimier A; Bodet D; Coze C; Deville A; Thebault E; Pasquier CJ; Cassagnau E; Pierron G; Clément N; Schleiermacher G; Amiel J; Delattre O; Peuchmaur M; Bourdeaut F
Pediatr Blood Cancer; 2016 Jan; 63(1):71-7. PubMed ID: 26375764
[TBL] [Abstract][Full Text] [Related]
19. Germline PHOX2B mutation in hereditary neuroblastoma.
Mosse YP; Laudenslager M; Khazi D; Carlisle AJ; Winter CL; Rappaport E; Maris JM
Am J Hum Genet; 2004 Oct; 75(4):727-30. PubMed ID: 15338462
[No Abstract] [Full Text] [Related]
20. A new familial cancer syndrome including predisposition to Wilms tumor and neuroblastoma.
Abbaszadeh F; Barker KT; McConville C; Scott RH; Rahman N
Fam Cancer; 2010 Sep; 9(3):425-30. PubMed ID: 20054657
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]